Form 5 Form 5A Form 5D Form 5E

Product Registration Process (Local Manufacturing / Finished Product Import of
Biologicals) for veterinary use
Process Description:
Name of Process Drug Product Registration for Local Manufacturing / Finished Product
Import-Biologicals) for veterinary use
Name of Application for registration of drug product for local manufacturing or
Business process finished product import (Biologicals) for veterinary use
Related Laws. • Drug Regulatory Authority of Pakistan Act, 2012.
Rules and • Drugs Act, 1976
regulations • The Drugs (Labeling & Packing) Rules, 1986
• The Drugs (Licensing, Registering & Advertising) Rules, 1976.
• The Drugs (Specification) Rules, 1978.
Input & Criteria • For local manufacturer; A valid Drug Manufacturing License (Form
to enter/begin 2) by DRAP
the business • For Finished product Import; A valid Drug Sale License and Sole
process Agency Agreement
Activities and Outline for drug product registration process of biologicals is as follows: -
associated
documentary 1. Registration Board is the relevant forum for consideration of
requirements registration applications
2. Applicant shall submit drug product registration application form as
per Rules 26 of Drugs (Licensing, Registering &Advertising) Rules,
1976 according to product type, as follows: -
For Veterinary Use:
• Form 5- Local Manufacturing,
• Form 5A – Imported Drugs,
• Form 5D New Drug Molecules,
• Form 5E, Patent Drugs
3. Applicant (manufacturer / importer) shall support drug product
registration application with requisite documents and fee.
4. Applicant submits the application to DRAP.
5. DRAP receives the application(s) which alongwith details is/are
entered in the database of received applications after its
categorization (routine/priority).
6. These applications are scrutinized and evaluated on FIFO basis as
per checklist approved by Registration Board.
• If the application is in-complete, DRAP informs the applicant
with observation note. One reminder is issued in case
applicant fails to reply in stipulated time period.
7. After rectification of shortcomings, Biological Evaluation &
Research (BE&R) of DRAP prepare the summary for consideration
of Registration Board.
8. For locally manufactured drugs, Registration Board may cause the
premises of drug manufacturer to be inspected by a panel of experts
and detail report shall be presented before the Registration Board.
9. For imported drugs, GMP inspection of foreign manufacturer is
carried out prior to grant of registration. However, pharmaceutical /
biological products approved by United States Food and Drug
Administration (USFDA), World Health Organization (WHO),
European Medicine Agency (EMA) or regulatory bodies of Japan,
Australia, Canada, or any of regulatory authority of erstwhile
Western Europe (United Kingdom, Germany, France, Switzerland,
Netherlands, Austria, Belgium, Denmark, Finland, Sweden, Italy,
Ireland, Luxemburg, Norway, Scotland and Spain) or three stringent
regulatory bodies of erstwhile Eastern Europe are exempted from
inspection.
10. Registration Board take the final decision.
11. If the Registration Board rejected the application, BE&R Division
informs the applicant (manufacturer /importer) for rejection of
application.
12. If MRP is already fixed by Federal Government, Pharmaceutical
Evaluation & Registration, Division of DRAP issues Certificate of
Registration of approved drug product to the applicant (manufacturer
/ importer).
13. In case, the MRP is not fixed, matter is referred to Costing & Pricing
Division for fixation of price by the Federal Government under the
Drug Pricing Policy. The certificate of registration will be issued
after price fixation by Federal Government.
14. In case rejection of application by Registration Board, applicant has
the right of appeal within 60 days before the Appellate Board.
Output Criteria • Certificate of Registration (Form 6) of drug product from DRAP
to exit the office.
business process • Validity for 5 years (unless earlier cancelled or suspended by the
Registration Board)
• Legal Reference: Drug Regulatory Authority of Pakistan Act, 2012
and The Drug (Licensing, Registering & Advertising) Rules, 1976
Time required to • Minimum: 03 months
exit the business • Maximum: 18 months
process
Fee •PKR 20,000/- For local manufacturing Drug (PKR 1,00,000/-, In
case a product contains imported pellets)
• PKR 50,000/- For contract manufacturing
• PKR 1,00,000/- For Imported Drug
• PKR 50,000/- For New Drug Molecules
(Fee are prescribed in schedule F of The Drug (Licensing, Registering &
Advertising) Rules, 1976 as amended Vide SRO 1117 dated 12th September,
2012.

Form 5 Form 5A Form 5D Form 5E

Uploaded by

Copyright:

Available Formats

Form 5 Form 5A Form 5D Form 5E

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Form 5 Form 5A Form 5D Form 5E

Uploaded by

Copyright:

Available Formats

Product Registration Process (Local Manufacturing / Finished Product Import of

Biologicals) for veterinary use

You might also like